United Therapeutics | UTHR - Market Capitalization

Stock Price
536.12
Daily Change
3.30 0.62%
Monthly
11.13%
Yearly
74.50%
Q1 Forecast
519.93

United Therapeutics reported $25.07B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amarin USD 341M 4M Sep/2025
Ardelyx USD 1.33B 390M Sep/2025
Baxter International USD 9.82B 1.87B Dec/2025
Bayer EUR 36.89B 535.42M Mar/2026
BioCryst Pharmaceuticals USD 1.56B 14M Dec/2024
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025